-- 
Allied Irish, Aviva, Pearson: U.K., Irish Equity Market Preview

-- B y   B l a n c h e   G a t t   a n d   J u l i e   C r u z
-- 
2011-04-12T06:28:37Z

-- http://www.bloomberg.com/news/2011-04-11/allied-irish-aviva-pearson-u-k-irish-equity-market-preview.html
The following is a list of
companies that may have unusual share-price changes in U.K. and
Irish markets. Stock symbols are in parentheses and prices are
from the last market close.  The benchmark  FTSE 100 Index (UKX)  declined 2.31 points, or less
than 0.1 percent, to 6,053.44. The  FTSE All-Share Index (ASX)  fell 0.1
percent while Ireland’s ISEQ Index retreated 1.2 percent.  Allied Irish Banks Plc (ALBK)  : The Dublin-based,
government-controlled lender said it will eliminate more than
2,000 jobs after posting a record 10.4 billion-euro ($15
billion) net loss on continuing operations last year. The shares
dropped 11 percent to 25 euro cents.  Aviva Plc (AV/)  : Britain’s second-biggest insurer by
market value plans to sell a 478 million-euro stake in Delta
Lloyd NV, the Dutch insurer it took public in 2009. The stock
advanced 0.1 percent to 452.7 pence.  Pearson Plc (PSON)  : The education and media publishing
company which owns the Financial Times newspaper has extended
the offer period for Education Development International Plc
(EDD LN) to April 26 after receiving acceptances representing
about 70.7 percent of the issued shared capital, Pearson said.
The shares were unchanged at 1,104 pence.  Schroders Plc (SDR)  : The largest publicly traded U.K.
fund manager was raised to “neutral” from “underperform” at
Credit Suisse Group AG. The shares climbed 0.4 percent to 1,823
pence.  St James’s Place Plc (STJ)  : The wealth manager majority-
owned by Lloyds Banking Group Plc was downgraded to “neutral”
from “buy” at UBS AG. The shares added 0.1 percent to 349.1
pence.  To contact the reporters on this story:
Blanche Gatt in London at 
 bgatt@bloomberg.net ;
Julie Cruz in Frankfurt at 
 jcruz6@bloomberg.net   To contact the editors responsible for this story:
Colin Keatinge at 
 ckeatinge@bloomberg.net ;
Andrew Rummer at 
 arummer@bloomberg.net  